Type
. Alteration in the lipid content of the blood and tissues in leprosy patients. Repura. 1958;27:5 p.
Type
. Cortisol and proinflammatory cytokine profiles in type 1 (reversal) reactions of leprosy. Immunology letters. 2013;156(1-2):159-67.
Type
. Twelve months fixed duration WHO multidrug therapy for multibacillary leprosy: incidence of relapses in Agra field based cohort study. Indian Journal of Medical Research [Internet]. 2013;38:536-540. Available from: http://icmr.nic.in/ijmr/2013/october/1011.pdf
Type
. Editor’s choice – September 2013. Leprosy review. 2013;84(3):175.
Type
. Buried within the abbey walls: Paleopathological examination of leprosy frequencies of a rural monastic population in medieval Denmark. [Ann Arbor]: Boston University; 2014. p. 159.
Type
. [Evaluation of surgical treatments for leprosy sequelae using the Salsa and Dash scales]. Revista Brasileira de Ortopedia (English Edition) [Internet]. 2014;49(3):292 - 296. Available from: http://ac.els-cdn.com/S2255497114000780/1-s2.0-S2255497114000780-main.pdf?_tid=cac59a30-86b5-11e4-a9dc-00000aacb362&acdnat=1418907787_abdb251cb2a8b2934cbe88c3378909a5
Type
. [Discussions regarding the reconstruction of the significance of leprosy in the post-sulfone period, Minas Gerais, in the 1950s.]. Historia, ciencias, saude--Manguinhos [Internet]. 2014;22(2):541-558. Available from: http://www.scielo.br/pdf/hcsm/2014nahead/0104-5970-hcsm-2014005000026.pdf
Type
. FoxP3 provides competitive fitness to CD4(+) CD25(+) T cells in leprosy patients via transcriptional regulation. European journal of immunology. 2013;.
Type
. Antioxidant factors, nitric oxide levels, and cellular damage in leprosy patients. Revista da Sociedade Brasileira de Medicina Tropical. 2013;46(5):645-649.
Type
. Clinical variables associated with leprosy reactions and persistence of physical impairment. Revista da Sociedade Brasileira de Medicina Tropical [Internet]. 2013;46(5):600-604. Available from: http://www.scielo.br/pdf/rsbmt/v46n5/0037-8682-rsbmt-42-2013.pdf